CorMedix names CFO, chief medical officer
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
CorMedix Inc. appointed Robert Cook as CFO and Judith Abrams to the new role of chief medical officer.
Cook previously served as Bio Blast Pharma Ltd.'s CFO, while Abrams recently served as head of Celgene Corp.'s Otezla global clinical submission team.